Prokineticins: From the Gastrointestinal Tract to Neuroinflammation: Molecular Mediators in Health and Disease: How Cells Communicate
Editat de Roberta Lattanzi, Rossella Mieleen Limba Engleză Paperback – feb 2027
The prokinetcin system is also explored in the context of neurodegenerative disease and traumatic brain injury, pain, inflammation, infection and cancer. It also investigates natural and pharmacological inhibitors of PK receptors and closes with a look towards future research perspectives.
- Explores the diverse physiological roles of prokineticins in neurogenesis, circadian rhythm, reproduction, and cardiovascular function
- Investigates the pathophysiological implications of altered prokineticin expression in diseases, including cancer, diabetes, and neurodegenerative disorders
- Highlights the therapeutic potential of prokineticin receptors as targets for treating cardiovascular, metabolic, and nervous system conditions
- Provides comprehensive analyses of endogenous peptides, synthetic ligands, and modulators of prokineticin receptors in preclinical models
- Serves as an essential resource for biologists, clinicians, and students, bridging gaps in understanding PKs across various fields
Preț: 1122.24 lei
Preț vechi: 1457.45 lei
-23% Precomandă
Puncte Express: 1683
Carte nepublicată încă
Livrare prin curier în România Precomanda se expediază când titlul devine disponibil.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Specificații
ISBN-13: 9780443456558
ISBN-10: 0443456550
Pagini: 480
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Seria Molecular Mediators in Health and Disease: How Cells Communicate
ISBN-10: 0443456550
Pagini: 480
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Seria Molecular Mediators in Health and Disease: How Cells Communicate
Cuprins
Part I. Introduction
1 Prokineticin phylogenesis: from early studies in frogs to mammals
2. Prokineticins: structure, distribution and regulation
3. Prokineticin receptors: structure, distribution and regulation
4. Prokineticin system: signal transduction
Part II. Relation structure-function
5. Prokineticins and splice isoforms
6. Prokineticin receptors and splicing isoforms
7. Structural elements underlying prokineticin-receptor interactions
8. Interaction of prokineticin receptors with accessory proteins
Part III. Physiological functions of the prokineticin system
9. Neurogenesis
10. Regulation of circadian rhythm
11. Regulation of food intake and energy balance
12. Regulation of the development and function of reproductive system.
13. Regulation of the development and function of heart
14. Regulation of the development and function of kidney
Part IV. The prokineticin system in neurogenesis disfunctions
15. The prokineticin system in Kallmann syndrome
16. The prokineticin system in Hirschprung disease
17. The prokineticin system in mood disorders and stress
Part V. The prokineticin system in obesity and diabetes
18. Central regulation of obesity through prokineticin signalling
19. Regulation of visceral adipose tissue growth by prokineticin signalling
20. The role of the prokineticin system in metabolic syndrome
21. The role of the prokineticin system in insulin resistance
22. The role of the prokineticin system in diabetes-mediated cardiomyopathy and diabetes-mediated skeletal muscle dysfunction
23. The role of prokineticin 2 in torpor and temperature regulation
Part VI. The prokineticin system in disorders of the reproductive system functions
24. The role of the prokineticin system in female infertility: gestational hypertension and pre-eclampsia
25. The role of the prokineticin system in male infertility: Klinefelter syndrome
Part VII. The prokineticin system in cardiovascular diseases
26. The role of the prokineticin system in cardiovascular diseases: myocardial infarction-induced heart failure
27. The role of the prokineticin system in the development of pathological hypertrophic cardiomyopathy
Part VIII. The prokineticin system in neurodegenerative disease and in neuronal injury
28. Alzheimer's disease
29. Parkinson’s disease
30. Traumatic brain injury
Part IX. The prokineticin system in pain
31. Nociceptive pain
32. Inflammatory pain
33. Neuropathic pain
34. Pleasant touch
Part X. The prokineticin system in autoimmunity, inflammation and infection
35. General inflammation
36. Multiple Sclerosis
37. Arthritis and Osteoarthritis
38. Gastro-intestinal inflammatory diseases
39. Covid
40. Chagas Disease
Part XI. The prokineticin system in cancer-related inflammation
41. Prokineticins and cancer progression
42. Prokineticins in different types of cancer
43. Prokineticins as biomarkers
Part XII. Natural and pharmacological inhibitors of PK receptors
44. Non peptide antagonists of the prokineticin receptors
45. Peptide antagonists of the prokineticin receptors
Part XIII - Conclusion
46. Future directions for PK research
1 Prokineticin phylogenesis: from early studies in frogs to mammals
2. Prokineticins: structure, distribution and regulation
3. Prokineticin receptors: structure, distribution and regulation
4. Prokineticin system: signal transduction
Part II. Relation structure-function
5. Prokineticins and splice isoforms
6. Prokineticin receptors and splicing isoforms
7. Structural elements underlying prokineticin-receptor interactions
8. Interaction of prokineticin receptors with accessory proteins
Part III. Physiological functions of the prokineticin system
9. Neurogenesis
10. Regulation of circadian rhythm
11. Regulation of food intake and energy balance
12. Regulation of the development and function of reproductive system.
13. Regulation of the development and function of heart
14. Regulation of the development and function of kidney
Part IV. The prokineticin system in neurogenesis disfunctions
15. The prokineticin system in Kallmann syndrome
16. The prokineticin system in Hirschprung disease
17. The prokineticin system in mood disorders and stress
Part V. The prokineticin system in obesity and diabetes
18. Central regulation of obesity through prokineticin signalling
19. Regulation of visceral adipose tissue growth by prokineticin signalling
20. The role of the prokineticin system in metabolic syndrome
21. The role of the prokineticin system in insulin resistance
22. The role of the prokineticin system in diabetes-mediated cardiomyopathy and diabetes-mediated skeletal muscle dysfunction
23. The role of prokineticin 2 in torpor and temperature regulation
Part VI. The prokineticin system in disorders of the reproductive system functions
24. The role of the prokineticin system in female infertility: gestational hypertension and pre-eclampsia
25. The role of the prokineticin system in male infertility: Klinefelter syndrome
Part VII. The prokineticin system in cardiovascular diseases
26. The role of the prokineticin system in cardiovascular diseases: myocardial infarction-induced heart failure
27. The role of the prokineticin system in the development of pathological hypertrophic cardiomyopathy
Part VIII. The prokineticin system in neurodegenerative disease and in neuronal injury
28. Alzheimer's disease
29. Parkinson’s disease
30. Traumatic brain injury
Part IX. The prokineticin system in pain
31. Nociceptive pain
32. Inflammatory pain
33. Neuropathic pain
34. Pleasant touch
Part X. The prokineticin system in autoimmunity, inflammation and infection
35. General inflammation
36. Multiple Sclerosis
37. Arthritis and Osteoarthritis
38. Gastro-intestinal inflammatory diseases
39. Covid
40. Chagas Disease
Part XI. The prokineticin system in cancer-related inflammation
41. Prokineticins and cancer progression
42. Prokineticins in different types of cancer
43. Prokineticins as biomarkers
Part XII. Natural and pharmacological inhibitors of PK receptors
44. Non peptide antagonists of the prokineticin receptors
45. Peptide antagonists of the prokineticin receptors
Part XIII - Conclusion
46. Future directions for PK research